Search
Go
Displaying Results for "usfda"
  • Nifty Pharma trades flat as FDA nods Gileads remdesivir for Covid-19 treatment; Torrent Pharma, Cipla top gainers

    Majority Indian listed pharma companies have the approval from Gilead to sell 'Remdesivir' under their respective brand name for Covid-19 treatment....

    India Infoline News Service | Mumbai 15:06 IST | October 23, 2020

  • Zydus Cadila gets USFDA nod for generic drug

    Drug firm Zydus Cadila on Friday said it has received approval from the US health regulator to market Albuterol tablets, used to treat shortness of breath caused by breathing problems such as asthma. The company has received final approval from the...

    Source : <a href='https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/zydus-cadila-gets-usfda-nod-for-generic-drug/articleshow/78824424.cms' target='_blank' rel='nofollow' >economictimes</a> | Mumbai 13:26 IST | October 23, 2020

  • Cadila Healthcare share price rises 2% post USFDA approval

    Cadila Healthcare share price rose 2% intraday on October 23 after it received final approval from United States Food and Drug Administration (USFDA). At 11:35 hrs Cadila Healthcare was quoting at Rs431.90, up Rs6.25, or 1.47% on the BSE. Zydus Cad...

    Source : <a href='https://www.moneycontrol.com/news/buzzing-stocks/cadila-healthcare-share-price-rises-2-post-usfda-approval_14397521.html' target='_blank' rel='nofollow' >MoneyControl</a> | Mumbai 12:17 IST | October 23, 2020

  • Zydus Cadila receives final approval from USFDA for Albuterol tablets to treat bronchospasm

    Zydus Cadila informed the exchanges that it has received final approval from the USFDA to market Albuterol Tablets. The tablets will be available in the strengths of 2 mg and 4 mg. Albuterol is a bronchodilator. It helps open up the airways in you...

    Source : <a href='https://www.indiainfoline.com/article/news-sector-pharma-healthcare/zydus-cadila-receives-final-approval-from-usfda-for-albuterol-tablets-to-treat-bronchospasm-120102300498_1.html' target='_blank' rel='nofollow' >Indiainfoline</a> | Mumbai 12:16 IST | October 23, 2020

  • Zydus Cadila receives final approval from USFDA for Albuterol tablets to treat bronchospasm

    The group now has 310 approvals and has so far filed over 390 ANDAs....

    India Infoline News Service | Mumbai 11:55 IST | October 23, 2020

  • Cadila Healthcare rises after final USFDA approval for Albuterol tablets

    Cadila Healthcare rises after final USFDA approval for Albuterol tablets cadila Healthcare rose 1.49% to Rs 431.75 after the company said it has received final approval from the US drug regulator to market Albuterol tablets in the strengths of 2 mg and 4 mg.

    capital market | Mumbai 11:55 IST | October 23, 2020

  • Zydus Cadila receives USFDA final approval for Albuterol Tablets

    Zydus Cadila receives USFDA final approval for Albuterol Tablets zydus Cadila receives USFDA final approval for Albuterol Tablets

    capital market | Mumbai 11:40 IST | October 23, 2020

  • Zydus Cadila receives USFDA final approval for Albuterol Tablets

    Zydus Cadila receives USFDA final approval for Albuterol Tablets zydus Cadila receives USFDA final approval for Albuterol Tablets

    capital market | Mumbai 00:00 IST | October 23, 2020

  • Aurobindo Pharma gets USFDA nod for pain treatment injection Acetaminophen

    Drug firm Aurobindo Pharma on Thursday said it has received final approval from the US health regulator for its generic Acetaminophen injection, used in the treatment of pain in adult and paediatric patients. The company now has a total of 449 ANDA...

    Source : <a href='https://www.business-standard.com/article/companies/aurobindo-pharma-gets-usfda-nod-for-pain-treatment-injection-acetaminophen-120102200601_1.html' target='_blank' rel='nofollow' >Business Standard</a> | Mumbai 14:23 IST | October 22, 2020

  • Aurobindo Pharma gets USFDA nod for pain treatment injection Acetaminophen

    Drug firm Aurobindo Pharma on Thursday said it has received final approval from the US health regulator for its generic Acetaminophen injection, used in the treatment of pain in adult and paediatric patients. The company now has a total of 449 ANDA...

    Source : <a href='https://www.business-standard.com/article/companies/aurobindo-pharma-gets-usfda-nod-for-pain-treatment-injection-acetaminophen-120102200601_1.html' target='_blank' rel='nofollow' >Business Standard</a> | Mumbai 14:18 IST | October 22, 2020

  • Aurobindo Pharma shares plunge over 6% after USFDA warning letter for subsidiary

    Shares of Aurobindo Pharma on Thursday tanked over 6% after the company's step-down subsidiary received a warning letter from the US health regulator for its unit in New Jersey, US. AuroLife Pharma, a wholly-owned step-down subsidiary of the company...

    Source : <a href='https://economictimes.indiatimes.com/markets/stocks/news/aurobindo-pharma-shares-plunge-over-6-after-usfda-warning-letter-for-subsidiary/articleshow/78804665.cms' target='_blank' rel='nofollow' >economictimes</a> | Mumbai 14:06 IST | October 22, 2020

  • Aurobindo Pharma receives USFDA final approval for Acetaminophen Injection

    Aurobindo Pharma receives USFDA final approval for Acetaminophen Injection aurobindo Pharma receives USFDA final approval for Acetaminophen Injection

    capital market | Mumbai 14:06 IST | October 22, 2020

  • Aurobindo Pharma receives USFDA approval for generic Acetaminophen injection for fever and pain relief

    Aurobindo Pharma Limited is pleased to announce that the company has received final approval from the US Food & Drug Administration (USFDA) to manufacture and market Acetaminophen Injection, 1,000. The approved product has an estimated market size o...

    Source : <a href='https://www.indiainfoline.com/article/news-sector-pharma-healthcare/aurobindo-pharma-receives-usfda-approval-for-generic-acetaminophen-injection-for-fever-and-pain-relief-120102200512_1.html' target='_blank' rel='nofollow' >Indiainfoline</a> | Mumbai 13:10 IST | October 22, 2020

  • Aurobindo Pharma receives USFDA approval for generic Acetaminophen injection for fever and pain relief

    The product will be launched in December 2020, the company said in the filing....

    India Infoline News Service | Mumbai 12:53 IST | October 22, 2020

  • Granules India gets USFDA approval for potassium chloride tablets

    Drug firm Granules India on Thursday said it has received marketing approval from the US health regulator for Potassium Chloride extended release tablets, used for treatment of patients with hypokalemia....

    Source : <a href='https://www.business-standard.com/article/companies/granules-india-gets-usfda-approval-for-potassium-chloride-tablets-120102200410_1.html' target='_blank' rel='nofollow' >Business Standard</a> | Mumbai 12:18 IST | October 22, 2020

  • Granules India gets USFDA nod for potassium chloride tablets used to treat hypokalemia

    Drug firm Granules India on Thursday said it has received marketing approval from the US health regulator for Potassium Chloride extended release tablets, used for treatment of patients with hypokalemia. Granules has received marketing approval from...

    Source : <a href='https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/granules-india-gets-usfda-nod-for-potassium-chloride-tablets-used-to-treat-hypokalemia/articleshow/78802684.cms' target='_blank' rel='nofollow' >economictimes</a> | Mumbai 11:56 IST | October 22, 2020

  • Aurobindo Pharma arm's New Jersey unit gets warning letter from USFDA

    Drug firm Aurobindo Pharma Thursday said its step-down subsidiary has received a warning letter from the US health regulator for its unit in New Jersey, US. AuroLife Pharma, a wholly-owned step-down subsidiary of the company, has received a warning...

    Source : <a href='https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/aurobindo-pharma-arms-new-jersey-unit-gets-warning-letter-from-usfda/articleshow/78802240.cms' target='_blank' rel='nofollow' >economictimes</a> | Mumbai 11:26 IST | October 22, 2020

  • Aurobindo Pharma declines 6% on USFDA warning letter for Dayton facility

    Shares of Aurobindo Pharma were down 6% to Rs755 on the BSE on Thursday after the company's arm has received a warning letter from the US health regulator for its oral solid manufacturing facility situated at Dayton, New Jersey....

    Source : <a href='https://www.business-standard.com/article/markets/aurobindo-pharma-dips-6-as-arm-received-warning-letter-for-dayton-facility-120102200370_1.html' target='_blank' rel='nofollow' >Business Standard</a> | Mumbai 11:00 IST | October 22, 2020

  • Granules rises after USFDA approval for generic drug

    Granules rises after USFDA approval for generic drug granules India rose 1% to Rs 389.35 after the company received US drug regulators approval for generic potassium chloride tablets for the treatment of Hypokalemia.

    capital market | Mumbai 10:44 IST | October 22, 2020